+ All Categories
Home > Documents > Contraceptive Prevalence MICS3 Data Analysis and Report Writing.

Contraceptive Prevalence MICS3 Data Analysis and Report Writing.

Date post: 27-Mar-2015
Category:
Upload: justin-hutchinson
View: 227 times
Download: 6 times
Share this document with a friend
Popular Tags:
15
Contraceptive Prevalence MICS3 Data Analysis and Report Writing
Transcript
Page 1: Contraceptive Prevalence MICS3 Data Analysis and Report Writing.

Contraceptive Prevalence

MICS3 Data Analysis and Report Writing

Page 2: Contraceptive Prevalence MICS3 Data Analysis and Report Writing.

Background

• Family planning is important for the health of women and children by– preventing pregnancies that are too early or too late

– extending the period between births

– limiting the number of children

Page 3: Contraceptive Prevalence MICS3 Data Analysis and Report Writing.

International Goals & Targets

Access by all couples to information and services to prevent pregnancies

that are too early, too closely spaced, too late or too many

Contraceptive prevalence rate

(MDG 6, Indicator 19C)

Page 4: Contraceptive Prevalence MICS3 Data Analysis and Report Writing.

Definition of Indicator

% women aged 15-49 years currently married or in union using a contraceptive method

Numerator: Number of women currently married or in union aged 15-49 years who are using (or whose partner is using) a contraceptive method (either modern or traditional)

Denominator: Number of women aged 15-49 years who are currently married or in union

Page 5: Contraceptive Prevalence MICS3 Data Analysis and Report Writing.

Methodological Issues

• Modern methods include female and male sterilization, pill, IUD, injectables, condom, diaphragm/foam/jelly

• Traditional methods include lactational amenorrhea method (LAM), periodic abstinence, withdrawal, other (usually folk) methods

• Any method includes modern or traditional methods

Contraceptive prevalence is reported separately for each method and grouped as follows:

Page 6: Contraceptive Prevalence MICS3 Data Analysis and Report Writing.

Methodological Issues

• Indicator refers to women currently married or ‘in union’

• In the MICS questionnaire, women who are currently pregnant are not asked about contraceptive use. It is assumed that they are not using contraception. But they are included in the denominator of the indicator.

• The MICS questionnaire allows respondents to name more than one method. If a woman says that she and her partner are using more than one method, she is categorized under the first method in the list of categories

Page 7: Contraceptive Prevalence MICS3 Data Analysis and Report Writing.
Page 8: Contraceptive Prevalence MICS3 Data Analysis and Report Writing.

Contraceptive Prevalence Rate

7972 69

5246

2817

60

0

20

40

60

80

100

Regional Contraceptive Prevalence

Page 9: Contraceptive Prevalence MICS3 Data Analysis and Report Writing.

Contraceptive Prevalence (CEE/CIS)

34

41

42

48

50

55

58

60

61

62

62

64

66

68

71

75

89

69

0 20 40 60 80 100

CEE/CIS

Tajikistan

Georgia

Bulgaria

Bosnia and Herzegovina

Belarus

Azerbaijan

Serbia and Montenegro

Kyrgyzstan

Armenia

Moldova, Republic of

Turkmenistan

Romania

Kazakhstan

Uzbekistan

Turkey

Albania

Ukraine

Contraceptive

Prevalence

Rate

Page 10: Contraceptive Prevalence MICS3 Data Analysis and Report Writing.

Contraceptive Prevalence (ROSA)

Contraceptive prevalence

46

10

28

31

38

39

47

59

70

0 20 40 60 80 100

South Asia

Afghanistan

Pakistan

Bhutan

Nepal

Maldives

India

Bangladesh

Sri Lanka

% contraceptive prevalence

Page 11: Contraceptive Prevalence MICS3 Data Analysis and Report Writing.

52

7

23

28

32

32

43

44

45

48

50

51

56

57

60

62

63

63

66

74

0 20 40 60 80 100

Middle East/North Africa

Sudan

Yemen

UAE

Oman

Saudi Arabia

Qatar

Iraq

Libya

Syria

Kuwait

OPT

Jordan

Algeria

Egypt

Bahrain

Lebanon

Morocco

Tunisia

Iran

% contraceptive prevalence

Contraceptive Prevalence (MENA)

Contraceptive

Prevalence

Rate

Page 12: Contraceptive Prevalence MICS3 Data Analysis and Report Writing.

72

273738

414243

4750

535455565657585858

6262

666667

696970

737374

777777

8084

0 20 40 60 80 100

Latin America/Caribbean

HaitiGuyana

Trinidad/TobagoSaint Kitts and Nevis

SurinameGuatemalaSaint Lucia

DominicaAntigua/Barbuda

GrenadaBarbados

BelizeChile

ParaguayBolivia

PanamaSaint Vincent/Grenadines

BahamasHonduras

EcuadorJamaica

El SalvadorNicaragua

PeruDR

CubaMexico

ArgentinaBrazil

ColombiaVenezuelaCosta Rica

Uruguay

Contraceptive Prevalence (TACRO)

Contraceptive

Prevalence

Rate

Page 13: Contraceptive Prevalence MICS3 Data Analysis and Report Writing.

79

1011

1721

242628303232333434

444445

495557

6269

74797981

87

0 20 40 60 80 100

East Asia/Pacific

Timor-Leste

Solomon Islands

Palau

Kiribati

Cambodia

PNG

Vanuatu

Samoa

Lao PDR

Tuvalu

Tonga

Marshall Islands

Myanmar

Cook Islands

Fiji

Micronesia

Philippines

Malaysia

Indonesia

Korea, DPR

Mongolia

Singapore

Thailand

Viet Nam

Korea, Rep of

China

Contraceptive Prevalence (EAPRO)

Contraceptive

Prevalence

Rate

Page 14: Contraceptive Prevalence MICS3 Data Analysis and Report Writing.

Contraceptive Prevalence (ESARO)

Contraceptive

Prevalence

Rate

28

1

688

1316

1723

26

2627

30

3134

3944

48

4854

5676

0 20 40 60 80 100

East/Southern Africa

Somalia

Angola

Eritrea

Ethiopia

Rwanda

Burundi

Mozambique

Uganda

Comoros

Tanzania

Madagascar

Lesotho

Malawi

Zambia

Kenya

Namibia

Botswana

Swaziland

Zimbabwe

South Africa

Mauritius

Page 15: Contraceptive Prevalence MICS3 Data Analysis and Report Writing.

Contraceptive Prevalence (WCARO)

Contraceptive

Prevalence

Rate

17

478888101113141415

1819

25262628293133

53

0 20 40 60 80 100

West/Central Africa

Sierra Leone

Guinea

Chad

Guinea-Bissau

Mali

Mauritania

Liberia

Senegal

Nigeria

Burkina Faso

Niger

Côte d'Ivoire

Gambia

Benin

Ghana

Cameroon

Togo

CAR

Sao Tome/Principe

Congo, Dem Rep

Gabon

Cape Verde


Recommended